These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 37047636)

  • 1. Mineral Metabolism in Children: Interrelation between Vitamin D and FGF23.
    Pons-Belda OD; Alonso-Álvarez MA; González-Rodríguez JD; Mantecón-Fernández L; Santos-Rodríguez F
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatonins: From Discovery to Therapeutics.
    Kritmetapak K; Kumar R
    Endocr Pract; 2023 Jan; 29(1):69-79. PubMed ID: 36210014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
    Liu S; Gupta A; Quarles LD
    Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J; Liu S; Quarles LD
    Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
    Sapir-Koren R; Livshits G
    Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF23 and Bone and Mineral Metabolism.
    Fukumoto S
    Handb Exp Pharmacol; 2020; 262():281-308. PubMed ID: 31792685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for FGF23 involvement in a bone-kidney axis regulating bone mineralization and systemic phosphate and vitamin D homeostasis.
    Martin A; Quarles LD
    Adv Exp Med Biol; 2012; 728():65-83. PubMed ID: 22396162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of FGF23 production and phosphate metabolism by bone-kidney interactions.
    Agoro R; White KE
    Nat Rev Nephrol; 2023 Mar; 19(3):185-193. PubMed ID: 36624273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.
    Hasegawa H; Nagano N; Urakawa I; Yamazaki Y; Iijima K; Fujita T; Yamashita T; Fukumoto S; Shimada T
    Kidney Int; 2010 Nov; 78(10):975-80. PubMed ID: 20844473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteo-renal cross-talk and phosphate metabolism by the FGF23-Klotho system.
    Ohnishi M; Razzaque MS
    Contrib Nephrol; 2013; 180():1-13. PubMed ID: 23652546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets.
    Wöhrle S; Henninger C; Bonny O; Thuery A; Beluch N; Hynes NE; Guagnano V; Sellers WR; Hofmann F; Kneissel M; Graus Porta D
    J Bone Miner Res; 2013 Apr; 28(4):899-911. PubMed ID: 23129509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism.
    Barthel TK; Mathern DR; Whitfield GK; Haussler CA; Hopper HA; Hsieh JC; Slater SA; Hsieh G; Kaczmarska M; Jurutka PW; Kolek OI; Ghishan FK; Haussler MR
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):381-8. PubMed ID: 17293108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal iron supplementation, FGF23, and bone metabolism in Kenyan women and their offspring: secondary analysis of a randomized controlled trial.
    Braithwaite VS; Mwangi MN; Jones KS; Demir AY; Prentice A; Prentice AM; Andang'o PEA; Verhoef H
    Am J Clin Nutr; 2021 May; 113(5):1104-1114. PubMed ID: 33675347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [FGF23 and skeletal metabolism].
    Michigami T
    Clin Calcium; 2014 Jun; 24(6):879-84. PubMed ID: 24870839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone and Calcium Research Update 2015. Novel treatment for FGF23-related hypophosphatemic diseases].
    Fukumoto S
    Clin Calcium; 2015 Jan; 25(1):37-44. PubMed ID: 25530521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FGF23/KLOTHO Regulatory Network and Its Roles in Human Disorders.
    Kinoshita S; Kawai M
    Vitam Horm; 2016; 101():151-74. PubMed ID: 27125741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minireview: fibroblast growth factor 23 in phosphate homeostasis and bone metabolism.
    Hori M; Shimizu Y; Fukumoto S
    Endocrinology; 2011 Jan; 152(1):4-10. PubMed ID: 21084445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System.
    Latic N; Erben RG
    Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum fibroblast growth factor 23 and mineral metabolism in patients with euthyroid Graves' diseases: a case-control study.
    Lin CH; Chang CK; Shih CW; Li HY; Chen KY; Yang WS; Tsai KS; Wang CY; Shih SR
    Osteoporos Int; 2019 Nov; 30(11):2289-2297. PubMed ID: 31384956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.